aRCC: 1L Treatment Options and Patient Management
ASCO GU 2022 Germline Mutations of Interests in Renal Cell Carcinoma
By
ASCO Genitourinary Cancers Symposium
FEATURING
Michael Dean
By
ASCO Genitourinary Cancers Symposium
FEATURING
Michael Dean
Login to view comments.
Click here to Login
aRCC: 1L Treatment Options and Patient Management